Clinical trial
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
NCT01860625 is registered in ClinicalTrials.gov with Icure Pharmaceutical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
- Lead sponsor
- Icure Pharmaceutical Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- February 28, 2014
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.